Charles Brigden
Director Ejecutivo en Eliptica Ltd. .
Perfil
Mr. Charles Brigden is Senior Vice President & Head-Business Development at BTG Plc.
He received his MBA from Columbia Business School.
Cargos activos de Charles Brigden
| Empresas | Cargo | Inicio |
|---|---|---|
Eliptica Ltd.
 Eliptica Ltd. Miscellaneous Commercial ServicesCommercial Services Eliptica Ltd. is a British company that specializes in research and experimental development on biotechnology. The private company was founded in 2022 by Markus Ralser, Aleksej Zelezniak, Charles Brigden. Charles Brigden has been the CEO since 2022. | Director Ejecutivo | 01/04/2022 |
Antiguos cargos conocidos de Charles Brigden.
| Empresas | Cargo | Fin |
|---|---|---|
| BTG | Corporate Officer/Principal | - |
Formación de Charles Brigden.
| Columbia Business School | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
Eliptica Ltd.
Eliptica Ltd. Miscellaneous Commercial ServicesCommercial Services Eliptica Ltd. is a British company that specializes in research and experimental development on biotechnology. The private company was founded in 2022 by Markus Ralser, Aleksej Zelezniak, Charles Brigden. Charles Brigden has been the CEO since 2022. | Commercial Services |
- Bolsa de valores
- Insiders
- Charles Brigden
